IL2 and alkaline phosphatase measurement: Similarly, decreased IL-2 release and 90% nonspecific mortality were observed after the intraperitoneal administration of lipopolysaccharide in mice with AP, and therapy with recombinant IL-2 reduced lipopolysaccharide-induced mortality in the later stages of the disease [24].